Love TED W
SEC-identified person · CIK 1188919 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Structure Therapeutics Inc. GPCR | Director | filed 2023 - 2026 |
| Royalty Pharma plc RPRX | Director | filed 2020 - 2026 |
| Gilead Sciences, INC. GILD | Director | filed 2024 - 2026 |
| Jazz Pharmaceuticals plc JAZZ | Director | filed 2025 - 2026 |
| Seagen Inc. SGEN | Director | filed 2020 - 2023 |
| Global Blood Therapeutics, Inc. GBT | Director · See Remarks. | filed 2015 - 2022 |
| Portola Pharmaceuticals INC PTLA | Director | filed 2019 - 2020 |
| Amicus Therapeutics, INC. [FOLD} | Director | filed 2012 - 2020 |
| Oncothyreon Inc. ONTY | Director | filed 2013 - 2018 |
| Kalobios Pharmaceuticals INC KBIOQ | Director | filed 2012 - 2015 |
| Santarus INC SNTS | Director | filed 2006 - 2014 |
| Savara Inc [ANX] | Director | filed 2012 - 2013 |
| Onyx Pharmaceuticals INC ONXX | EVP, R&D and Tech. Operations | filed 2010 - 2012 |
| Affymax INC AFFY | Director | filed 2006 - 2012 |
| BIO-RAD Laboratories, INC. bio,bio.b | Director | filed 2010 - 2010 |
| Oruka Therapeutics, Inc. ORKA | Director · President and C.E.O. | filed 2006 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.